TABLE 6

Effects of the change in Fa, i, Fg, i, fu, mic, and fp, i on the prediction of -fold increase in AUC (AUCs, day15/AUCs, day1) for plasma midazolam concentrations after repeated oral administration of FK1706 (60 mg) using a dynamic model developed in this study and in vitro CYP3A4/5 inactivation rate (kinact, vitro and KI, vitro and set of kdeg, g 0.0210 h−1 and kdeg, h 0.00495 h−1)

The values in the parentheses represent fu, mic, i, 0.05 mg/ml corresponding to the values of fu, mic, i, 0.3 mg/ml (Hallifax and Houston, 2006; Gertz et al., 2008). Observed AUCs, day15/AUCs, day1 was 2.

Parameter as VariablePredicted AUCs, day15/AUCs, day1
Final Model: TDI Intestine and Liver, Direct Intestine InhibitionSensitivity Analysis (Contribution of Each Dimension of the Inhibition)
TDI LiverDirect Intestine InhibitionTDI IntestineTDI Intestine, Direct Intestine InhibitionTDI Intestine and Liver
Fa, i
    0.11.431.081.061.281.321.39
    0.21.631.141.101.371.431.56
    0.52.081.361.201.451.531.98
    1a2.811.781.311.491.582.33
Fg, i
    0.11.701.081.311.491.581.61
    0.21.801.141.311.491.581.70
    0.52.151.361.311.491.582.03
    1a2.811.781.311.491.582.33
fu, mic, i, 0.3 mg/ml
    0.1 (0.4)8.545.311.421.531.618.15
    0.2 (0.6)5.203.261.361.521.604.96
    0.528a (0.87)2.811.781.311.491.582.33
    1 (1)2.161.391.281.461.552.02
fp, i
    0.0052.181.381.311.491.582.07
    0.01a2.811.781.311.491.582.33
    0.024.132.621.311.491.583.91
    0.057.664.861.311.491.587.25
  • a Default values.